Bio-Rad Laboratories, Inc. (BIO)

Healthcare · Medical Devices · NYSE

Bio-Rad Laboratories, Inc. (BIO) is a Healthcare company in the Medical Devices industry. It has a market capitalization of $10.15B, a trailing price-to-earnings ratio of 40.9 and a free-cash-flow yield of 3.6%. Over the most recent reported fiscal year, revenue grew 0.7% and free cash flow per share grew 45.5%.

Market cap	$10.15B
Trailing P/E	40.9
FCF yield	3.6%
Revenue growth (YoY)	+0.7%
EPS growth (YoY)	-3.8%
FCF/share growth (YoY)	+45.5%
Exchange	NYSE
Sector	Healthcare
Industry	Medical Devices

Explore live BIO data on Nama Insights →

Recent Congressional trades

Bio-Rad Laboratories, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Lois Frankel	House	Sell	$1,001 - $15,000	Oct 10, 2023
Thomas R Tillis	Senate	Sell	$1,001 - $15,000	—